Brain Ultrafast Ultrasound Imaging
Brain Ultrafas
2 other identifiers
observational
300
1 country
1
Brief Summary
Congenital heart defects affect 1 in 100 births in France, with rising prevalence due to better care. Despite improved survival, 40% of children post-surgery face neurological impairments, and some of them show brain lesions. Causes include heart defects, genetic syndromes, and surgeries. Some heart defects and support systems increase cerebral risks. Monitoring cerebral perfusion is difficult to assess but emerging ultrafast ultrasound offers real-time, non-invasive blood flow insights.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedFirst Posted
Study publicly available on registry
December 23, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
ExpectedDecember 23, 2025
December 1, 2025
Same day
November 19, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cerebral blood volume variation
Depending on stage of medico-surgical treatment
at baseline
Cerebral blood volume variation
Depending on hemodynamic or ventilatory situation, and exposure to vasoactive or neuroactive drugs.
at baseline
Secondary Outcomes (13)
Evolution of Arterial blood pressure
at baseline
Evolution of central venous blood pressure
at baseline
Evolution of left atrial pressure
at baseline
Evolution of SpO2
at baseline
Evolution of SaO2
at baseline
- +8 more secondary outcomes
Study Arms (1)
Patient receiving a transcranial Doppler
Every patient receiving a transcranial Doppler in routine care in our CHD unit of intensive care and anaesthesiology for cardiovascular surgery department
Interventions
Ultrafast ultrasound imaging(UFUS), ultrasound images at a very high rate, using a Verasonics system (ultrasound open platform).
Eligibility Criteria
Every patient, under two years old, receiving a transcranial Doppler in routine care in our CHD unit of intensive care and anaesthesiology for cardiovascular surgery department.
You may qualify if:
- Every patient under 2 years old any sex or gender hospitalised in the congenital heart disease unit of the intensive care and anaesthesia for cardiovascular surgery, CHU de Bordeaux.
- Open anterior fontanella
- congenital heart disease
- cardiac shock necessitating mechanical circulatory support.
- Social security affiliation
- Parental or legal guardian's non-opposition
You may not qualify if:
- Anechoic
- Allergy to echocardiography gel.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haut Lévêque Cardiology Hospital
Pessac, France, 33604, France
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2025
First Posted
December 23, 2025
Study Start
January 1, 2026
Primary Completion
January 1, 2026
Study Completion (Estimated)
January 1, 2029
Last Updated
December 23, 2025
Record last verified: 2025-12